Seminars in Nephrology
Volume 28, Issue 3 , Pages 217-226 , May 2008

Dissecting the Roles of Aquaporins in Renal Pathophysiology Using Transgenic Mice

  • A.S. Verkman, MD, PhD

      Affiliations

    • Corresponding Author InformationAddress reprint requests to Alan S. Verkman, MD, PhD, 1246 Health Sciences East Tower, Cardiovascular Research Institute, University of California, San Francisco, San Francisco, CA 94143-0521.

References 

  1. Nielsen S, Frokiaer J, Marples D, et al. Aquaporins in the kidney: from molecules to medicine. Physiol Rev. 2002;82:205–244
  2. Verkman AS. More than just water channels: unexpected cellular roles of aquaporins. J Cell Sci. 2005;118:3225–3232
  3. Zhang D, Vetrivel L, Verkman AS. Aquaporin deletion in mice reduces intraocular pressure and aqueous fluid production. J Gen Physiol. 2002;119:561–569
  4. Oshio K, Song Y, Verkman AS, et al. Reduced intraventricular pressure and cerebrospinal fluid production in mice lacking aquaporin-1 water channels. FASEB J. 2005;18:76–78
  5. Ma T, Song Y, Gillespie A, Carlson EJ, et al. Defective secretion of saliva in transgenic mice lacking aquaporin-5 water channels. J Biol Chem. 1999;274:20071–20074
  6. Song Y, Verkman AS. Aquaporin-5 dependent fluid secretion in airway submucosal glands. J Biol Chem. 2001;276:41288–41292
  7. Verkman AS, Binder DK, Block O, et al. Three distinct roles of aquaporin-4 in brain function revealed by knockout mice. Biochem Biophys Acta. 2006;1758:1085–1093
  8. Manley GT, Fujimura M, Ma T, et al. Aquaporin-4 deletion in mice reduces brain edema after acute water intoxication and ischemic stroke. Nat Med. 2000;6:159–163
  9. Papadopoulos MC, Manley GT, Krishna S, Verkman AS. Aquaporin-4 facilitates reabsorption of excess fluid in vasogenic brain edema. FASEB J. 2004;18:1291–1293
  10. Binder DK, Yao X, Sick TJ, et al. Increased seizure duration and slowed potassium kinetics in mice lacking aquaporin-4 water channels. Glia. 2006;53:631–636
  11. Padmawar P, Yao X, Bloch O, et al. K+ waves in brain cortex visualized using a long-wavelength K+-sensing fluorescent indicator. Nat Methods. 2005;2:825–827
  12. Hara M, Verkman AS. Glycerol replacement corrects defective skin hydration, elasticity, and barrier function in aquaporin-3-deficient mice. Proc Natl Acad Sci U S A. 2003;100:7360–7365
  13. Hara-Chikuma M, Sohara E, Rai T, et al. Progressive adipocyte hypertrophy in aquaporin-7 deficient mice: adipocyte glycerol permeability as a novel regulator of fat accumulation. J Biol Chem. 2005;280:15493–15496
  14. Hibuse T, Maeda N, Funahashi T, et al. Aquaporin 7 deficiency is associated with development of obesity through activation of adipose glycerol kinase. Proc Natl Acad Sci U S A. 2005;102:10993–10998
  15. Ma T, Yang B, Gillespie A, et al. Severely impaired urinary concentrating ability in transgenic mice lacking aquaporin-1 water channels. J Biol Chem. 1998;273:4296–4299
  16. Ma T, Song Y, Yang B, et al. Nephrogenic diabetes insipidus in mice deficient in aquaporin-3 water channels. Proc Natl Acad Sci U S A. 2000;97:4386–4391
  17. Chou CL, Knepper MA, Van Hoek AN, et al. Reduced water permeability and altered ultrastructure in thin descending limb of Henle in aquaporin-1 null mice. J Clin Invest. 1999;103:491–496
  18. Schnermann J, Chou CL, Ma T, et al. Defective proximal tubular fluid reabsorption in transgenic aquaporin-1 null mice. Proc Natl Acad Sci U S A. 1998;95:9660–9664
  19. Vallon V, Verkman AS, Schnermann J. Luminal hypotonicity in proximal tubules of aquaporin-1 knockout mice. Am J Physiol. 2000;278:F1030–F1033
  20. Pallone TL, Edwards A, Ma T, et al. Requirement of aquaporin-1 for NaCl driven water transport across descending vasa recta. J Clin Invest. 2000;105:215–222
  21. Ma T, Yang B, Gillespie A, et al. Generation and phenotype of a transgenic knock-out mouse lacking the mercurial-insensitive water channel aquaporin-4. J Clin Invest. 1997;100:957–962
  22. Chou CL, Ma T, Yang B, et al. Four-fold reduction in water permeability in inner medullary collecting duct of aquaporin-4 knockout mice. Am J Physiol. 1998;274:C549–C554
  23. Robben JH, Knoers NV, Deen PM. Cell biological aspects of the vasopressin type-2 receptor and aquaporin-2 water channel in nephrogenic diabetes insipidus. Am J Physiol. 2006;291:F257–F270
  24. Deen PM, Croes H, van Aubel RA, et al. Water channels encoded by mutant aquaporin-2 genes in nephrogenic diabetes insipidus are impaired in their cellular routing. J Clin Invest. 1995;95:2291–2296
  25. Tamarappoo BK, Verkman AS. Misfolding of mutant aquaporin-2 water channels in nephrogenic diabetes insipidus. J Biol Chem. 1999;274:34825–34831
  26. Tamarappoo BK, Verkman AS. Defective trafficking of AQP2 water channels in nephrogenic diabetes insipidus and correction by chemical chaperones. J Clin Invest. 1998;101:2257–2263
  27. Yang B, Gillespie A, Carlson EJ, et al. Early neonatal mortality in a transgenic AQP2 knock-in model of nephrogenic diabetes insipidus. J Biol Chem. 2001;276:2775–2779
  28. Yang B, Zhou D, Qain L, et al. Mouse model of inducible nephrogenic diabetes insipidus produced by floxed aquaporin-2 gene deletion. Am J Physiol. 2006;291:F465–F472
  29. Rojek A, Füchtbauer EM, Kwon TH, et al. Severe urinary concentrating defect in renal collecting duct-selective AQP2 conditional-knockout mice. Proc Natl Acad Sci U S A. 2006;103:6037–6042
  30. Lloyd DJ, Hall FW, Tarantino LM, et al. Diabetes insipidus in mice with a mutation in aquaporin-2. PLoS Genet. 2005;19:1;:e20
  31. Sohara E, Rai T, Yang SS, et al. Pathogenesis and treatment of autosomal-dominant nephrogenic diabetes insipidus caused by an aquaporin 2 mutation. Proc Natl Acad Sci U S A. 2006;103:14217–14222
  32. Sohara E, Rai T, Miyazaki J, et al. Defective water and glycerol transport in the proximal tubules of AQP7 knockout mice. Am J Physiol. 2005;289:F1195–F1200
  33. Yakata K, Hiroaki Y, Ishibashi K, et al. Aquaporin-11 containing a divergent NPA motif has normal water channel activity. Biochim Biophys Acta. 2007;1768:688–693
  34. Morishita Y, Matsuzaki T, Hara-Chikuma M, et al. Disruption of aquaporin-11 produces polycystic kidneys following vacuolization of the proximal tubule. Mol Cell Biol. 2005;25:7770–7779
  35. Papadopoulos MC, Saadoun S, Verkman AS. Aquaporins and cell migration. Pflugers Arch. 2008 (in press).
  36. Saadoun S, Papadopoulos MC, Hara-Chikuma M, Verkman AS. Impairment of angiogenesis and cell migration by targeted of aquaporin-1 gene disruption. Nature. 2005;434:786–792
  37. Auguste K, Jin J, Uchida K, et al. Greatly impaired migration of implanted aquaporin-4 deficient astroglial cells in mouse brain toward a site of injury. FASEB J. 2007;21:108–116
  38. Hu J, Verkman AS. Increased migration and metastatic potential of tumor cells expressing aquaporin water channels. FASEB J. 2006;20:1892–1894
  39. Levin MH, Verkman AS. Aquaporin-3-dependent cell migration and proliferation during corneal re-epithelialization. Invest Opthalmol Vis Sci. 2006;47:4365–4372
  40. Hara-Chikuma M, Verkman AS. Aquaporin-3 facilitates epidermal cell migration and proliferation during wound healing. J Mol Med. 2008;86:221–231
  41. Hara-Chikuma M, Verkman AS. Aquaporin-1 facilitates migration of epithelial cells in kidney proximal tubule. J Am Soc Nephrol. 2006;17:39–45
  42. Thiagarajah JR, Zhao D, Verkman AS. Impaired enterocyte proliferation in aquaporin-3 deficiency in mouse models of colitis. Gut. 2008;56:1529–1535
  43. Hara-Chikuma M, Verkman AS. Prevention of skin tumorigenesis and impairment of epidermal cell proliferation by targeted aquaporin-3 gene disruption. Mol Cell Biol. 2008;28:328–332
  44. Carlsson O, Nielsen S, Zakaria R, et al. In vivo inhibition of transcellular water channels (aquaporin-1) during acute peritoneal dialysis in rats. Am J Physiol. 1996;271:H2254–H2262
  45. Yang B, Folkesson HG, Yang J, et al. Reduced water permeability of the peritoneal barrier in aquaporin-1 knockout mice. Am J Physiol. 1999;276:C76–C81
  46. Ni J, Verbavatz JM, Rippe A, et al. Aquaporin-1 plays an essential role in water permeability and ultrafiltration during peritoneal dialysis. Kidney Int. 2006;69:1518–1525

 Supported by grants DK35124, DK72517, EY13574, EB00415, HL59198, and HL73856 from the National Institutes of Health, and Research Development Program and Drug Discovery grants from the Cystic Fibrosis Foundation.

PII: S0270-9295(08)00047-8

doi: 10.1016/j.semnephrol.2008.03.004

Seminars in Nephrology
Volume 28, Issue 3 , Pages 217-226 , May 2008

Article Tools

* Image Usage & Resolution